Skip to main content
Clinical Trials/CTRI/2024/02/062681
CTRI/2024/02/062681Not yet recruitingPhase 4

Comparative evaluation of effectiveness of diclofenac sodium gel (3%) phonophoresis and piroxicam gel (0.5%) phonophoresis in management of temporomandibular disorders – a single blind, randomized controlled trial. - TMDS

Shruti Saryam0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients fulfilling the Diagnostic criteria for temporomandibular disorders
  • (DC/TMD) for Pain-Related temporomandibular disorders which include
  • Myalgia (Local myalgia, myofascial pain, and myofascial pain with referral}
  • and Arthralgia.
  • 2.Recurrent and chronic history of pain
  • 3.Pharmacologic washout of =72 hours for central analgesic, NSAIDS, and
  • antidepressants.
  • 4.Patients who have given Informed consent.

Exclusion Criteria

  • 1.Patients fulfilling the DC/TMD CRITERIA of Diagnostic Procedures for Pain Related temporomandibular disorder which include Headache attributed
  • to TMD, Disc derangement , Degenerative joint disease, Subluxation.
  • ? Patients on analgesics or anti-inflammatory medication who are not
  • willing to discontinue
  • 2.Patients on Physiotherapy /complementary and alternative medicine for
  • the same problem.
  • 3.Patient giving previous history of allergy to diclofenac sodium and
  • piroxicam drugs.
  • 4.Patients with cardiac pacemakers and implanted defibrillators
  • 5.Patients with jaw Tumors , fractures
  • 6.Systemically compromised patients
  • 7.Pregnant females
  • 8.Patient not willing to give informed consent.

Investigators

Sponsor
Shruti Saryam

Similar Trials

Comparative evaluation of effectiveness of... | Clinical Trial